The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease

BACKGROUND: Huntington's disease (HD) is a progressive neurodegenerative disorder caused by a CAG repeat expansion within the huntingtin gene. Mutant huntingtin protein misfolds and accumulates within neurons where it mediates its toxic effects. Promoting mutant huntingtin clearance by activati...

Descripción completa

Detalles Bibliográficos
Autores principales: Fox, Jonathan H, Connor, Teal, Chopra, Vanita, Dorsey, Kate, Kama, Jibrin A, Bleckmann, Dorothee, Betschart, Claudia, Hoyer, Daniel, Frentzel, Stefan, DiFiglia, Marian, Paganetti, Paolo, Hersch, Steven M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908080/
https://www.ncbi.nlm.nih.gov/pubmed/20569486
http://dx.doi.org/10.1186/1750-1326-5-26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908080/
https://www.ncbi.nlm.nih.gov/pubmed/20569486
http://dx.doi.org/10.1186/1750-1326-5-26

Ejemplares similares